GEN-001 Plus Pembrolizumab for Patients With Advanced Refractory Biliary Tract Cancer
Genome & Company
Genome & Company
Gustave Roussy, Cancer Campus, Grand Paris
Massachusetts General Hospital
Rain Oncology Inc
King Faisal Specialist Hospital & Research Center
National Institutes of Health Clinical Center (CC)
TerSera Therapeutics LLC
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
AIO-Studien-gGmbH
Spectrum Pharmaceuticals, Inc
Columbia University
Georgetown University
Samsung Medical Center
Gyeongsang National University Hospital